- SEK1.29bn
- SEK1.20bn
- SEK128.95m
Brief: Genovis Appoints Johan Dahlberg As CFO
Brief: Genovis, MGI Tech Expand Collaboration
Sweden's Genovis Q1 sales rise on pharma customer growth
Brief: Genovis Q1 EBITDA SEK 9.51 Million
Brief: Genovis Enters Into License Agreement With U.S. Biotech Company
Brief: Genovis, Single Cell Discoveries Enter Strategic Partnership
Sweden's Genovis Q4 sales rise 44% but miss estimates
Brief: Genovis Q4 EBITDA SEK 11.737 Million
Brief: Genovis Q3 Adjusted EBITDA Up At SEK 6.88 Mln
Brief: Genovis Receives Order From Pharmaceutical Company
Brief: Genovis Q2 EBITDA Up At SEK 6 Mln
Brief: Genovis Exercises Call Option To Acquire Remaining Shares In Sequrna
Brief: Genovis Q4 Net Sales SEK 27.9 Million
Brief: Genovis Q4 EBITDA SEK 7.771 Million
Brief: Genovis Q3 EBITDA Up At SEK 24.6 Mln
Brief: Genovis Q2 EBITDA SEK 5.272 Million
Brief: Genovis Announces Strategic Divestment Of Antibody Business To Leinco Technologies Inc
Brief: Genovis To Own 25% Of Sequrna Following Strategic Investment
Brief: Genovis Expects To Reach Full-Year Launch Targets In Q2